INTERRELATIONSHIPS OF RELATIVE RISKS OF BIRTH-DEFECTS IN EMBRYONIC AND FETAL DEATHS, IN LIVEBIRTHS, AND IN ALL CONCEPTUSES

被引:6
作者
REGAL, RR [1 ]
HOOK, EB [1 ]
机构
[1] UNIV CALIF BERKELEY,SCH PUBL HLTH,WARREN HALL,BERKELEY,CA 94720
关键词
RELATIVE RISKS; BIRTH DEFECTS; SPONTANEOUS ABORTION; EMBRYO DEATH; FETAL DEATH; DOWN SYNDROME; CONGENITAL HEART DEFECT;
D O I
10.1097/00001648-199205000-00010
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Most studies of associations with birth defects are undertaken in livebirths. An observed association in livebirths different from unity may be compatible with no association in conceptuses if "balanced" by a particular relative risk in embryonic and fetal deaths. We derived formulae to address the following queries: (1) If one observes in livebirths a relative risk of birth defect, r(def,lb,) then, with what combinations of relative risk of defect in embryonic and fetal deaths, r(def,efd,) and in all conceptuses, r(def,) is this value compatible? (2) What balancing relative risk in embryonic and fetal deaths is predicted if there is no causal association in all conceptuses? (3) Under what circumstances is there no relative risk in embryonic and fetal deaths that can balance an observed relative risk in livebirths? We present an expression for r(def,efd) in terms of five other variables: r(def,lb,) r(def,) and r(efd) (the relative risk of embryonic or fetal death), and the lethalities of the average (unexposed) conceptus and of the (unexposed) defective conceptus. This equation enables one to derive the balancing relative risk in embryonic and fetal deaths, bal r(def,efd,) which is the value of r(def,efd) when r(def) = 1.0. If bal r(def,efd) is negative, no such balancing relative risk exists, and any observed association in livebirths is incompatible with a null association in all conceptuses, that is, the association cannot be explained completely by differential selection of conceptuses with defect.
引用
收藏
页码:247 / 252
页数:6
相关论文
共 25 条
[1]  
Harlap S., Shiono P.H., Ramcharan S., A life table of spontaneous abortions and the effects of age, parity, and other variables, Human Embryonic and Fetal Death, pp. 145-158, (1980)
[2]  
Kline J., Stein Z., Susser M., Conception to Birth: Epidemiology of Prenatal Development, Oxford University Press, pp. 43-68, (1989)
[3]  
Hellmann K., Duke D.I., Tucker D.F., Prolongation of skin homograft survival by thalidomide, Br Med J, 2, pp. 687-689, (1965)
[4]  
Hellmann K., Immunosuppression by thalidomide: Implications for teratology, Lancet, 1, pp. 1136-1137, (1966)
[5]  
Nishimura H., Takano K., Tanimura T., Yasuda M., Normal and abnormal development of human embryos: First report of the analysis of 1,213 intact embryos, Teratology, 1, pp. 281-290, (1968)
[6]  
Lenz W., Immunsuppressive wirkung von Thalidomid?, Dtsch Med Wochenschr, 91, pp. 1132-1133, (1966)
[7]  
Stein Z., Susser M., Warburton D., Wittes J., Kline J., Spontaneous abortion as a screening device, Am J Epidemiol, 102, pp. 275-290, (1975)
[8]  
Roberts C.J., Lowe C.R., Where have all the conceptions gone?, Lancet, 1, pp. 498-499, (1975)
[9]  
Warkany J., Terathanasia, Teratology, 17, pp. 187-192, (1978)
[10]  
Khoury M.J., Flanders W.D., James L.M., Erickson J.D., Human teratogens, prenatal mortality and selection bias, Am J Epidemiol, 130, pp. 361-370, (1989)